
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 3 chart positions in 3 markets.
By chart position
- 🇺🇸US · Science#10030K to 100K
- 🇮🇩ID · Science#983K to 10K
- 🇰🇪KE · Science#101500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
17K to 57K🎙 ~2x weekly·216 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
34K to 113K🇺🇸88%🇮🇩9%🇰🇪3% - Active Followers
Loyal subscribers who consistently listen
10K to 34K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 16 epsHosts
Recent guests
Recent episodes
Cyclospora, Ticks, and Mosquitoes: Summertime Threats
Jul 16, 2026
Episode 212: Major Roadblocks
Jul 2, 2026
Episode 211: A System Held With Duct Tape
Jun 18, 2026
Episode 210: Ebola: What the Past Tells Us about the Present
Jun 4, 2026
Episode 209: Awareness vs. Alarm: Making Sense of the Headlines
May 21, 2026
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/16/26 | infectious diseasescyclospora+4 | — | CIDRAP | Democratic Republic of Congo | cyclosporaticks+5 | — | — | ||
| 7/2/26 | Ebola outbreakflu outbreak+4 | Dr. Michael Osterholm | CDC | TexasDRC | Ebolaflu+6 | — | — | ||
| 6/18/26 | Ebola outbreakpublic health+5 | — | HPV VaccineCIDRAP+7 | DRC | EbolaWorld Cup+5 | — | — | ||
| 6/4/26 | Ebola outbreakU.S. response+5 | Chris Dall | CIDRAPFDA+5 | Democratic Republic of Congo | Ebolahantavirus+5 | — | — | ||
| 5/21/26 | hantavirusEbola+4 | Chris Dall | The Vaccine Integrity ProjectCIDRAP | Democratic Republic of the Congo | hantavirusEbola+5 | — | — | ||
| 5/7/26 | COVID-19Paxlovid trials+5 | Chris Dall | PaxlovidCDC+9 | — | PaxlovidCOVID-19+6 | — | — | ||
| 4/23/26 | CDC Director nominationvaccine support+3 | Chris Dall | CDCTrump's administration+8 | — | CDCvaccine skepticism+3 | — | — | ||
| 4/9/26 | long COVIDCDC testing pause+4 | Chris Dall | AntidepressantCDC+2 | South CarolinaChicago | long COVIDCDC+5 | — | — | ||
| 3/26/26 | vaccine policyCOVID vaccine harms+5 | Chris Dall | Health Secretary RFK JrCIDRAP+1 | UKCalifornia | vaccine recommendationsCOVID+5 | — | — | ||
| 3/12/26 | COVID-19flu+5 | Chris Dall | CIDRAPGavi+5 | — | COVID-19flu+7 | — | — | ||
| 2/26/26 | vaccine updatesFDA decisions+4 | Chris Dall | FDACDC+7 | — | Moderna vaccineFDA+7 | — | — | ||
| 2/12/26 | vaccine trustmeasles outbreaks+3 | Chris Dall | CDCACLU+1 | El PasoAfrica | vaccineCDC+5 | — | — | ||
| 1/29/26 | immunizationmeasles+4 | Chris Dall | CDCWHO+1 | Minnesota | immunizationCDC+6 | — | — | ||
| 1/15/26 | childhood immunization scheduleinfluenza season+4 | Chris Dall | CIDRAPVoices for Vaccines+6 | — | immunizationinfluenza+5 | — | — | ||
| 1/2/26 | flu seasonMMR vaccine+3 | Chris Dall | Vaccine Integrity ProjectVoices for Vaccines+4 | — | fluMMR vaccine+3 | — | — | ||
| 12/18/25 | vaccine schedulespublic health+3 | Chris Dall | Voices for VaccinesFamilies Fighting Flu+4 | — | vaccinesafety net+3 | — | — |
Showing 16 of 16
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Osterholm Update
Peaked at #98 in ID, currently #98 in ID.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| ID | — | #98 | #98 | — |
| United States | — | #100 | #100 | — |
| KE | — | #101 | #101 | — |
Chart Positions
3 placements across 3 markets.
Chart Positions
3 placements across 3 markets.